Schrodinger is a scientific leader in developing chemical simulation software for use in pharmaceutical and biotechnology research. The company s products range from general molecular modeling programs to a full-featured suite of drug design software, including both ligand and structure-based methods. The company provides a complete suite of software that addresses the challenges in pharmaceutical research. For structure-based drug design, Prime is an accurate protein structure prediction package. Schrodinger serves a variety of clients, including Novartis Pharmaceuticals, Pfizer, Johnson & Johnson and Lexicon Pharmaceuticals. Founded in 1990, Schrodinger has operations in New York, Oregon and California.